Lessons from the National institutes of health innovation corps program: defining barriers to developing and commercializing novel solutions for persons with opioid use disorder

Lessons from the National institutes of health innovation corps program: defining barriers to developing and commercializing novel solutions for persons with opioid use disorder

Abstract Background Translating innovative research advancements into commercially viable medical interventions presents well-known challenges. However, there is limited understanding of how specific patient, clinical, social, and legal complexities have further complicated and delayed the developme...

Full description

Saved in:
Bibliographic Details
Main Authors: Matthew P. Heshmatipour, Tyler M. Duvernay, Desislava Z. Hite, Eboo Versi, Michael P. Hite, David F. Reeser, Victor Prikhodko, Ariana M. Nelson, Bina Julian, Milton L. Greenberg
Format: Article
Language:English
Published: BMC 2025-03-01
Series:Addiction Science & Clinical Practice
Subjects:
Opioid use disorder (OUD)
Stigma
Clinicians
Medical devices
Therapeutics commercialization
Online Access:https://doi.org/10.1186/s13722-025-00554-1
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s13722-025-00554-1

Similar Items